Japanese drugmaker Takeda has said it will exercise its option to buy UK-based GammaDelta Therapeutics, a specialist in 'off-the-shelf' cell therapies for solid tumours and blood cancers. The two ...
Takeda has announced a $100 million collaboration with Abingworth to work with GammaDelta Therapeutics, a UK biotech which is pioneering a novel type of T cell therapy. The Japanese pharma company, ...
Abstract: This work aims to find discriminative EEG-based features and appropriate classification methods that can categorise brainwave patterns based on their level of activity or frequency for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback